SANEGENEBIO Trademark

Trademark Overview

On Tuesday, June 27, 2023, a trademark application was filed for SANEGENEBIO with the United States Patent and Trademark Office. The USPTO has given the SANEGENEBIO trademark a serial number of 98061872. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 12, 2024. This trademark is owned by Suzhou Sanegene Bio Inc.. The SANEGENEBIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
sanegenebio

General Information

Serial Number98061872
Word MarkSANEGENEBIO
Filing DateTuesday, June 27, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, March 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, July 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSuzhou Sanegene Bio Inc.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSuzhou, Jiangsu 215103
CN

Trademark Events

Event DateEvent Description
Sunday, July 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 12, 2024ASSIGNED TO EXAMINER
Tuesday, March 12, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 12, 2024NON-FINAL ACTION E-MAILED
Tuesday, March 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, May 8, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, June 7, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, June 7, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords

sanegenebio diseases pharmaceutical delivery compounds infections viral targeted preparations based therapies